<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0024">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Skulnick</surname>
    <given-names>H. I.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Weed</surname>
    <given-names>S. D.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Eidson</surname>
    <given-names>E. E.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Renis</surname>
    <given-names>H. E.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wierenga</surname>
    <given-names>W.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Stringfellow</surname>
    <given-names>D. A.</given-names>
   </name>
  </person-group> (
  <year>1985</year>). 
  <article-title>Pyrimidinones. 1. 2-amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-inducing antiviral agents</article-title>. 
  <source>
   <italic>Journal of Medicinal Chemistry</italic>
  </source>, 
  <volume>28</volume>(
  <issue>12</issue>), 
  <fpage>1864</fpage>â€“
  <lpage>1869</lpage>. doi:
  <pub-id pub-id-type="doi">10.1021/jm00150a018</pub-id>
  <pub-id pub-id-type="pmid">2999405</pub-id>
 </mixed-citation>
</ref>
